Opportunity Information: Apply for RFA MH 19 412

The Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum funding opportunity (RFA-MH-19-412) is a National Institutes of Health (NIH) discretionary grant program using the R01 mechanism, with clinical trials allowed but not required ("Clinical Trial Optional"). Its overall purpose is to strengthen HIV prevention by tackling intersectional stigma, meaning the overlapping and reinforcing effects of multiple stigmatized identities (for example, stigma related to race/ethnicity, sexual orientation, gender identity, substance use, poverty, immigration status, involvement with the criminal legal system, or sex work). The FOA focuses on how these combined stigmas can block people from getting HIV tested and from successfully linking to and staying engaged in ongoing HIV prevention services.

The opportunity supports two main types of research. First, it encourages studies that improve how intersectional stigma is measured and understood, including creating or refining tools and metrics that capture real-world experiences of layered stigma across settings (such as healthcare, community environments, and social networks). In addition to measurement development, this research track also emphasizes identifying mechanisms and pathways, essentially mapping how intersectional stigma leads to reduced HIV testing, delayed engagement with prevention, poor linkage to services, or drop-off along the HIV prevention continuum. Projects under this aim would typically try to clarify where stigma shows up (interpersonal interactions, institutional policies, clinic practices, internalized stigma), how it affects behavior and decision-making, and what factors mediate or moderate its impact.

Second, the FOA supports the development and testing of interventions specifically designed to reduce intersectional stigma and improve HIV prevention outcomes. This includes designing approaches that can be implemented in clinical, community, or hybrid settings and then evaluating whether these interventions increase uptake of HIV testing and strengthen linkage to prevention services, including ongoing prevention engagement among key populations at substantial risk for HIV infection. Because the announcement is "clinical trial optional," applicants can propose either observational/mechanistic studies or intervention studies that may rise to the level of a clinical trial, depending on the design.

From an administrative standpoint, the program is offered as a grant, with an award ceiling listed as $499,999. The original closing date in the source information is 2019-01-23, and the FOA record shows a creation date of 2018-11-23. The CFDA numbers associated with this opportunity are 93.242 and 93.307, indicating the federal assistance listings tied to NIH programs relevant to the topic area.

Eligibility is broad and includes many types of applicants across government, academia, nonprofit, and private sectors. Eligible applicants explicitly include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; and small businesses. The FOA also highlights additional eligible applicant groups such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, regional organizations, and non-U.S. entities (foreign organizations). In practical terms, this broad eligibility signals an interest in supporting research that is scientifically rigorous while also being grounded in the communities most affected, including work led by or conducted in partnership with community organizations and institutions serving populations disproportionately impacted by HIV and stigma.

Taken together, PRISM is aimed at producing both better science (more accurate measurement and clearer causal explanations of how intersectional stigma disrupts prevention) and actionable solutions (interventions that reduce stigma and measurably improve HIV testing and prevention linkage). The emphasis on key populations at substantial risk for HIV infection and on improving the prevention continuum indicates that applicants are expected to connect stigma reduction not just to attitudes or experiences, but to concrete prevention outcomes such as testing uptake and successful connection to ongoing prevention services.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Promoting Reductions in Intersectional StigMa (PRISM) to Improve the HIV Prevention Continuum (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.307.
  • This funding opportunity was created on 2018-11-23.
  • Applicants must submit their applications by 2019-01-23. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $499,999.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA MH 19 412

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Awards for Faculty

Previous opportunity: Diabetes Research Centers (P30)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA MH 19 412

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA MH 19 412) also looked into and applied for these:

Funding Opportunity
Enabling Technologies to Accelerate Development of Oral Biodevices (R43/R44 Clinical Trial Not Allowed) Apply for PA 19 076

Funding Number: PA 19 076
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed) Apply for PA 19 081

Funding Number: PA 19 081
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) Apply for PAR 19 079

Funding Number: PAR 19 079
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed) Apply for PA 19 082

Funding Number: PA 19 082
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed) Apply for PA 19 083

Funding Number: PA 19 083
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Enabling Technologies to Accelerate Development of Oral Biodevices (R41/R42 Clinical Trial Not Allowed) Apply for PA 19 075

Funding Number: PA 19 075
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed) Apply for PA 19 077

Funding Number: PA 19 077
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing Development of Rapid Fungal Diagnostics (R01 Clinical Trial Not Allowed) Apply for PA 19 080

Funding Number: PA 19 080
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) Apply for PAR 19 078

Funding Number: PAR 19 078
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol-HIV/AIDS Program Project (P01 Clinical Trial Optional) Apply for RFA AA 19 002

Funding Number: RFA AA 19 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Emotion Regulation, Aging and Mental Disorder (R01 Clinical Trial Not Allowed) Apply for PA 19 094

Funding Number: PA 19 094
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
A Practice-Based Research Network to Transform Mental Health Care: Science, Service Delivery and Sustainability (U19 Clinical Trial Required) Apply for RFA MH 19 225

Funding Number: RFA MH 19 225
Agency: National Institutes of Health
Category: Health
Funding Amount: $130,000
Genetic Engineering Technologies for HIV Cure Research (U19 Clinical Trial Optional) Apply for RFA AI 18 058

Funding Number: RFA AI 18 058
Agency: National Institutes of Health
Category: Health
Funding Amount: $175,000
Exploring Molecular Links Between Dietary Interventions and Circadian Rhythm (R01 Clinical Trial Not Allowed) Apply for RFA AG 19 029

Funding Number: RFA AG 19 029
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed) Apply for PAS 19 097

Funding Number: PAS 19 097
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Emotion Regulation, Aging and Mental Disorder (R21 Clinical Trial Not Allowed) Apply for PA 19 095

Funding Number: PA 19 095
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed) Apply for PA 19 096

Funding Number: PA 19 096
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HEAL Initiative: Biofabricated 3D Tissue Models of Nociception, Opioid Use Disorder and Overdose for Drug Screening (UH2/UH3 Clinical Trial Not Allowed) Apply for RFA TR 19 005

Funding Number: RFA TR 19 005
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Heal Initiative: Pragmatic Randomized Controlled Trial of Acupuncture for Management of Chronic Low Back Pain in Older Adults (UG3/UH3 Clinical Trial Required) Apply for RFA AT 19 005

Funding Number: RFA AT 19 005
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
HEAL Initiative: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Anatomical and Functional Mapping of Pain-Related Visceral Organ Neural Circuitry (U01 Clinical Trial Optional) Apply for RFA RM 19 001

Funding Number: RFA RM 19 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 19 412", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: